Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)
Public ClinicalTrials.gov record NCT04644120. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of ABBV-47D11 and ABBV-2B04 as Monotherapy or Combination Therapy in Adults With COVID-19
Study identification
- NCT ID
- NCT04644120
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 25 participants
Conditions and interventions
Conditions
Interventions
- ABBV-47D11 Drug
- Placebo for ABBV-47D11 Drug
- ABBV-2B04 Drug
- Placebo for ABBV-2B04 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 9, 2020
- Primary completion
- Aug 23, 2021
- Completion
- Aug 23, 2021
- Last update posted
- Sep 1, 2021
2020 – 2021
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Glendale Adventist Medical Center /ID# 225188 | Glendale | California | 91206-4007 | — |
| Beautiful Minds Clinical Research Center /ID# 228708 | Cutler Bay | Florida | 33157-6608 | — |
| University of Miami /ID# 225038 | Miami | Florida | 33136 | — |
| Triple O Research Institute /ID# 228612 | West Palm Beach | Florida | 33407-3100 | — |
| University of Illinois Hospital and Health Sciences System /ID# 224323 | Chicago | Illinois | 60612-7232 | — |
| Pikeville Medical Center /ID# 224539 | Pikeville | Kentucky | 41501-1689 | — |
| Saint Peter's University Hospital /ID# 225183 | New Brunswick | New Jersey | 08901-1766 | — |
| Saint Michael's Medical Center /ID# 225258 | Newark | New Jersey | 07102 | — |
| The Christ Hospital /ID# 224541 | Cincinnati | Ohio | 45219 | — |
| Prisma Health Children's Hospital Upstate /ID# 224556 | Greenville | South Carolina | 29605-4210 | — |
| Gadolin Research, LLC /ID# 229394 | Beaumont | Texas | 77702-1100 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04644120, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 1, 2021 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04644120 live on ClinicalTrials.gov.